Possible new dwarf planet spotted near the edge of the solar system
By Will Dunham
WASHINGTON (Reuters) -Scientists have identified an object about 435 miles (700 km) wide inhabiting the frigid outer reaches of our solar system that might qualify as a dwarf planet, spotting it as it travels on a highly elongated orbital path around the sun.
The researchers called it one of the most distant visible objects in our solar system, and said its existence indicates that a vast expanse of space beyond the outermost planet Neptune and a region called the Kuiper Belt may not be deserted, as long thought. The Kuiper Belt is populated by numerous icy bodies.
Given the name 2017 OF201, the object falls into a category called trans-Neptunian objects that orbit the sun at a distance beyond that of Neptune. The object takes about 25,000 years to complete a single orbit of the sun, compared to 365 days for Earth to do so.
The researchers said 2017 OF201 was identified in observations by telescopes in Chile and Hawaii spanning seven years.
"It is potentially large enough to qualify as a dwarf planet. Its orbit is very wide and eccentric, which means it experienced an interesting orbital migration path in the past," said astrophysicist Sihao Cheng of the Institute for Advanced Study in Princeton, New Jersey, who led the study with collaborators Jiaxuan Li and Eritas Yang, graduate students at Princeton University.
Its size is estimated to be a bit smaller than Ceres, which is the smallest of the solar system's five recognized dwarf planets and has a diameter of about 590 miles (950 km). Pluto, the largest of those dwarf planets, has a diameter of about 1,477 miles (2,377 km).
The mass of 2017 OF201 is estimated to be about 20,000 times smaller than Earth's and 50 times smaller than Pluto's.
"We don't know the shape yet. Unfortunately it is too far away and it is a bit difficult to resolve it with telescopes," Cheng said. "Its composition is totally unknown yet, but likely similar to other icy bodies."
The discovery was announced by the Minor Planet Center of the International Astronomical Union, an international organization of astronomers, and detailed in a study posted on the open-access research site arXiv. The study has not yet been peer reviewed.
Earth's orbital distance from the sun is called an astronomical unit. 2017 OF201 is currently located at a distance of 90.5 astronomical units from the sun, meaning 90.5 times as far as Earth.
But at its furthest point during its orbit, 2017 OF201 is more than 1,600 astronomical units from the sun, while the closest point on its orbit is about 45 astronomical units. That means it sometimes is closer to the sun than Pluto, whose orbital distance ranges from 30 to 49 astronomical units as it travels an elliptical path around the sun.
The researchers suspect that the extreme orbit of 2017 OF201 may have been caused by a long-ago close encounter with the gravitational influence of a giant planet.
"We still don't know much about the solar system far away because currently it is difficult to directly see things beyond about 150 astronomical units," Cheng said. "The presence of this single object suggests that there could be another hundred or so other objects with similar orbit and size. They are just too far away to be detectable right now."
The five dwarf planets recognized by the International Astronomical Union are, in order of distance from the sun: Ceres, which is the largest object in the asteroid belt between Mars and Jupiter, then Pluto, Haumea, Makemake and Eris, which all orbit beyond Neptune.
The organization defines a planet and a dwarf planet differently. A planet must orbit its host star - in our case the sun - and must be mostly round and sufficiently large that its gravitational strength clears away any other objects of similar size near its orbit. A dwarf planet must orbit the sun and be mostly round but it has not cleared its orbit of other objects.
Cheng said the discovery of 2017 OF201 has implications for hypotheses involving the potential existence of a ninth planet in our solar system, dubbed Planet X or Planet Nine.
This is because 2017 OF201's orbit does not follow the pattern exhibited by other known trans-Neptunian objects, which tend to cluster together. Some scientists had hypothesized that such clustering was caused by the gravity of a yet-to-be discovered planet.
"The existence of 2017 OF201 as an outlier to such clustering could potentially challenge this hypothesis," Cheng said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Momentum builds for Israel-Syria peace as Trump reboots regional diplomacy
For the first time, Syrians are openly calling for peace with Israel. In an interview with Fox News Digital, journalist Furat Alali from Damascus said, "We want a future without wars. We want to live. People are not afraid to speak up anymore." Her statement reflects a significant shift in the country's political landscape, as many Syrians begin to openly discuss the prospect of peace with Israel. This change comes at a time when Syria and Israel are engaged in direct talks as Reuters revealed on Tuesday, marking a dramatic departure from the decades-long hostility between the two nations. Reuters reported, Israel and Syria have recently held direct meetings focused on security issues along their shared border. These talks represent a major step in the relationship between the two countries, which have been adversaries for decades. A Weakened Hezbollah Leads Some In Lebanon To Talk Of Peace With Israel As Us Pushes Sides Together Sources familiar with the discussions have indicated that the U.S. has played a pivotal role in facilitating these talks, encouraging Syria's new leadership to engage with Israel. The discussions come after a shift in U.S. policy, following President Donald Trump's meeting with Syrian interim President Ahmed al-Sharaa earlier this month. The meeting signaled a break from decades of U.S. hostility toward Syria's Assad regime and opened the door to potential normalization between Syria and Israel. Read On The Fox News App While the talks are still in the early stages, Trump's engagement has raised the possibility of Syria's leadership eventually normalizing ties with Israel, although this process will likely take time. Furat Alali explained: "We don't want to be part of the Axis of Resistance anymore. The Palestinian cause has been used to oppress us. We feel sympathy for the Palestinians, but now we need to focus on Syria and our future." Lina Ali, a 24-year-old pharmacist from Latakia, told Fox News Digital, "We feel for the people of Gaza. We condemn the mass killings, but we are in a different situation. We are thinking about our own interests now. The idea of exploiting the Palestinian cause to oppress the Syrian people has been rejected. We are tired of this." Another young woman interviewed by Jusoor News, a Pan-Arab media outlet, shared similar thoughts: "We are for anything that serves our country's interest. We've lived through difficult times. The country's economy is very weak. It's time for people to live." Fall Of Syria's Bashar Assad Is Strategic Blow To Iran And Russia, Experts Say An elderly Syrian man explained to Jusoor, "We've spent 40-50 years preaching Arabism and liberating Palestine, and what do we have to show for it? Nothing. It's time for peace." The shift in Syria's stance on Israel is significant, especially given the historical enmity between the two nations. For decades, Syria and Israel have been locked in conflict, with the status of the Golan Heights remaining a key point of contention since its capture by Israel during the 1967 war. Syria's involvement in the Axis of Resistance, aligning with Iran and Hezbollah against Israel, has been a cornerstone of its foreign policy. However, the recent emergence of interim president Ahmed al-Sharaa has raised new possibilities, as well as concerns. Furat Ali said, "I was one of the journalists who extensively covered the violations of Jabhat al-Nusra before the fall of the Assad regime, the group Al-Jolani emerged from (using his previous name), which was part of al-Qaeda. I know exactly what they did. So, when I first heard that Al-Jolani was taking over Aleppo and challenging Assad, I was scared." "But as time went on," she added, "when he rebranded himself as Ahmed al-Sharaa and promised a new direction, I saw he was smart. He managed to convince the West to lift sanctions and engage with him, bringing back international recognition for Syria. While we remain skeptical and cautious, what we're seeing from Sharaa domestically is so far being accepted." Joseph Braude, founder and president of the Center for Peace Communications, highlighted the significance of the shift in public opinion within Syria. He noted, "People in Syria and Lebanon often associate the Palestinian issue with dictators who exploited it to justify corruption and brutality. There is a growing rejection of pro-Palestinian militancy, as many people now desire to turn the page and focus on new partnerships aimed at developing their own countries. "We believe that it has become a majority view in Syria that if peace with Israel brings economic development and improvements, then it's worth pursuing." He also pointed out that in countries dominated by Iran and its militias, ordinary people have the clearest understanding of the harm these groups cause. "They are among the most eager for a different future, increasingly calling for peace," Braude added. As one man interviewed by Jusoor News put it: "We've suffered years of oppression and war. It's time for reconstruction. We need peace with everyone," another Syrian added' "I support normalization a million percent! If normalization with Israel, or America or whoever can bring us comfort, then I'm on board. We just want peace!"Original article source: Momentum builds for Israel-Syria peace as Trump reboots regional diplomacy
Yahoo
2 hours ago
- Yahoo
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds
By Julie Steenhuysen CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard treatments cut the risk of disease progression or death by half, a finding that could change the way such cancers are treated, cancer experts said on Sunday. The results, presented at the American Society of Clinical Oncology meeting in Chicago, mark the first use of a blood test called a liquid biopsy to indicate the need for a change in treatment in women with a common form of breast cancer, even before tumor growth can be detected on imaging. The early switch approach in women with hormone receptor-positive, HER2-negative breast cancer resulted in a 56% reduction in the risk of disease progression or death, said Dr. Eleonora Teplinsky, an oncologist at Valley-Mount Sinai Comprehensive Cancer Care and an ASCO breast cancer expert. "When patients progress on scans, we're already behind," Teplinsky said at a media briefing. She said an early switch approach, before disease progression, allows doctors "to essentially stay ahead of the curve." Camizestrant is not yet FDA-approved, but Teplinsky believes the data will likely result in a new treatment paradigm. The trial involved 3,256 patients with advanced hormone receptor-positive, HER2-negative breast cancer, the most common type in which hormones such as estrogen fuel cancer growth. These cancers lack high levels of HER2, another cancer driver. Women in the trial had at least six months of treatment with aromatase inhibitors that block hormones fueling the cancer, as well as targeted drugs called CDK4/6 inhibitors such as Novartis' Kisqali, Pfizer's Ibrance or Lilly's Verzenio, which block an enzyme that fuels cancer growth. About 40% of patients treated with aromatase inhibitors develop mutations in the estrogen receptor 1 gene called ESR1 mutations, a sign of early drug resistance. Camizestrant and similar drugs called Selective Estrogen Receptor Degraders (SERDS) block estrogen receptor signaling in cancer cells. In the trial, researchers used blood tests to look for ESR1 mutations until 315 patients were identified. They were randomly assigned to either switch to camizestrant plus the CDK4/6 inhibitor (157 patients) or continue with standard treatment plus a placebo (158 patients). The researchers found that it took 16 months for the disease to progress in women who got camizestrant, compared with 9.2 months in those who continued on standard therapy, a statistically significant difference in progression-free survival. No new side effects were reported and few patients from either group dropped out due to side effects. "This is going to be very impactful for our patients," said Dr. Hope Rugo, head of breast medical oncology at City of Hope in Duarte, California. The question, she said, is how do doctors incorporate the testing into clinical practice. Separately, adding AstraZeneca's immunotherapy durvalumab to standard treatment before and after surgery in patients with early-stage stomach and esophageal cancers helped extend the time patients had without cancer progression or recurrence compared to chemotherapy alone. The global study of nearly 950 patients tested durvalumab, sold under the brand Imfinzi, in combination with a chemotherapy regimen called FLOT given around the time of initial cancer surgery. Patients in the durvalumab plus FLOT arm experienced a 29% better event-free survival than those who received the chemotherapy regimen. "We demonstrate that immunotherapy works in early-stage disease, which is great," lead study author Dr. Yelena Jarnigan of Memorial Sloan Kettering Cancer Center in New York told reporters at the meeting. "We did not see any new safety signals, so this will change practice for our patients, which is exciting to see." Both studies were published on Sunday in the New England Journal of Medicine.
Yahoo
9 hours ago
- Yahoo
Jerrauld C. Jones, civil rights pioneer and state delegate, dies at 70
NORFOLK, Va. (WAVY) — Jerrauld C. Jones, a longtime judge and state delegate, has died at 70. In a statement issued by the Jones family, they announced he died on Saturday, May 31. 'It is with deep sorrow that we announce the passing of Jerrauld C. Jones,' the letter said. 'His legacy of service, integrity, and dedication to justice will continue to inspire all who knew him.' Jones became one of the first African American students to integrate Ingleside Elementary School in 1961 and later the Virginia Episcopal School in Lynchburg in 1967. Jones went on to graduate cum laude from Princeton University in 1976 and earned his Juris Doctor from Washington and Lee University School of Law in 1980. He became the first African American law clerk to the Supreme Court of Virginia, served as a Democratic member of the Virginia House of Delegates for 14 years, represented Norfolk's 89th District and served as the long-time chair of the Virginia Legislative Black Caucus. Virginia Speaker of the House Don Scott offered his condolences in a statement. Scott and Jones served together in the General Assembly. 'Jerrauld Jones was more than a judge or a legislator — he was a giant. A presence. A mentor. A friend. For so many of us, he was a guiding light. He spent his life breaking down barriers — integrating Virginia Episcopal School, becoming the first Black law clerk to the Virginia Supreme Court, serving in the House of Delegates, and later as a respected judge. 'But Jerrauld's legacy wasn't about titles — it was about how he treated people. At Grace Episcopal Church, he welcomed me and my family, and had a steady, genuine way of making others feel like they belonged. 'To his wife, Judge Lyn Simmons, and to Jay — I feel your loss deeply. My heart is with you, and I hope you find comfort in knowing how many lives Jerrauld touched and how much he meant to all of us.' Jerrauld Jones is survived by his wife, the Hon. Lyn Simmons, who serves on the Norfolk Juvenile and Domestic Relations District Court; their son, Jay Jones, a former member of the Virginia House of Delegates and his wife Mavis; and two grandsons Charles and Zachary. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.